Updated:
Blackrock Neurotech
Blackrock Neurotech — co-founded by Marcus Gerhardt, builds brain-computer interfaces from human clinical studies spanning over 19 years.
Blackrock Neurotech
Blackrock Neurotech was co-founded by Marcus Gerhardt and Professor Florian Solzbacher. Solzbacher, also a professor at the University of Utah, brings deep academic ties to the enterprise. The firm's board is co-chaired by Christian Angermayer, a German entrepreneur who runs Apeiron Investment Group and founded ATAI Life Sciences, and Tim Sievers, former CEO of fintech unicorn Deposit Solutions. The company develops implanted brain-computer interfaces (BCIs) for people with paralysis and neurological disorders. Its technology is used in over 1,000 labs globally, and it claims more than 19 years of human studies and 30,000-plus cumulative days of implant research (per the firm's website). Published studies have shown users decoding up to 62 words per minute from thought, and controlling robotic arms, Photoshop, and video games. Geography is global, with headquarters in Salt Lake City and mentions of other locations in San Mateo, San Francisco, and Tel Aviv. The firm has no disclosed AUM or external capital commitment figures. Team size is not publicly stated. Adjacent structures include co-chairman Angermayer's Apeiron Investment Group, a family office that invests in biotech, fintech, and deep tech. No recent operational event from the last 24 months was surfaced in the available sources. A structural distinctive of Blackrock Neurotech is its academic-industrial hybrid — Solzbacher's ongoing professorship at the University of Utah ties the firm directly to federally funded neuroscience research and a pipeline of engineering talent. This model blends university spinout dynamics with private capital to fund long-horizon hardware development.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Salt Lake City
Corporate office
630 Komas Drive, Suite 200, Salt Lake City, UT 84108, United States
Principals
Marcus Gerhardt
Co-Founder & CEO
Florian Solzbacher
Co-Founder & CSO
Christian Angermayer
Co-Chairman
Tim Sievers
Co-Chairman
Thomas Thiele
CFO
Sector focus
Frequently asked questions
Who runs investment decisions at Blackrock Neurotech?
Marcus Gerhardt serves as CEO. The board is co-chaired by Christian Angermayer, founder of Apeiron Investment Group, and Tim Sievers, founder of Deposit Solutions. Strategic direction involves both executive leadership and academic co-founder Florian Solzbacher (per the firm's website).
How does Blackrock Neurotech source its technology and IP?
The core technology originates from research at the University of Utah, where co-founder Florian Solzbacher holds a chaired professorship. The firm has licensed or transferred university-developed patents into a commercial platform, typical of university spinouts in the neurotechnology space.
Is Blackrock Neurotech a single family office or does it operate more like a venture firm?
Blackrock Neurotech is a private operating company developing medical devices, not a family office or asset manager. Its capital structure is opaque, but its governance includes a board co-chaired by Christian Angermayer, whose family office Apeiron Investment Group frequently backs deep tech companies.
Does Blackrock Neurotech accept outside capital or only rely on internal funding?
The firm does not publicly disclose its capital sources. Its website lists no funds or investment vehicles for external investors. Given the capital-intensive nature of medical device development, undisclosed private funding rounds or grants are likely.
What investment stages does Blackrock Neurotech typically target?
The firm does not invest in external companies — it is an operating company that develops and commercializes its own neurotechnology products. Its stage focus is on clinical and commercial deployment rather than external portfolio building.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: